Form 4 holding
SVP Finance, CFO
GLYCOMIMETICS INC
- Security class
- Common Stock
- Shares / value
- 70,643
- Estimated value
- $17,498
- Report date
- 18 Jun 2024
- Price
- $0.2477
- Ownership
- Direct
Brian M. Hahn - SVP Finance, CFO at CRESCENT BIOPHARMA, INC.
Issuer-level insider activity
- Role
- SVP Finance, CFO
- Issuer ticker
- CBIO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Brian M. Hahn since 20 Sep 2025
Reported holdings for Brian M. Hahn in CRESCENT BIOPHARMA, INC.
Form 4 holding
SVP Finance, CFO
GLYCOMIMETICS INC
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 250,000
- Estimated value
- Report date
- 12 Jan 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Brian M. Hahn in CRESCENT BIOPHARMA, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.